Vol 28, No 1 (2021)
Technology Note
Published online: 2020-12-01

open access

Page views 750
Article views/downloads 815
Get Citation

Connect on Social Media

Connect on Social Media

First-in-human radiofrequency ablation of ventricular tachycardia performed through an Atrial Flow Regulator device

Mateusz Wilkowski1, Łukasz Lewicki23, Rafał Olszewski1, Adam Priebe3, Miłosz J. Jaguszewski2, Marek Szołkiewicz3
Pubmed: 33346370
Cardiol J 2021;28(1):161-162.

Abstract

Not available

Article available in PDF format

View PDF Download PDF file

References

  1. Muser D, Liang JJ, Santangeli P. Electrical storm in patients with implantable cardioverter-defibrillators: a practical overview. J Innov Card Rhythm Manag. 2017; 8(10): 2853–2861.
  2. Lewicki Ł, Sabiniewicz R, Siebert J, et al. Atrial flow regulator as a novel therapy for patients with chronic heart failure. Cardiol J. 2020; 27(3): 309–311.
  3. Paitazoglou C, Özdemir R, Pfister R, et al. The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction. EuroIntervention. 2019; 15(5): 403–410.